Provided by Tiger Trade Technology Pte. Ltd.

CervoMed

2.57
+0.09003.63%
Post-market: 2.630.0600+2.33%19:30 EDT
Volume:234.57K
Turnover:601.11K
Market Cap:38.86M
PE:-0.80
High:2.64
Open:2.54
Low:2.50
Close:2.48
52wk High:10.00
52wk Low:2.13
Shares:15.12M
Float Shares:9.60M
Volume Ratio:1.21
T/O Rate:2.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1959
EPS(LYR):-2.9824
ROE:-107.62%
ROA:-60.80%
PB:1.69
PE(LYR):-0.86

Loading ...

CervoMed Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

Cervomed Q1 FY26 net loss widens 63% to $7.96 million

Reuters
·
May 15

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 15

CervoMed Inc expected to post a loss of 78 cents a share - Earnings Preview

Reuters
·
May 09

CervoMed announces annual shareholder meeting webcast

Reuters
·
Apr 30

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cochlear (OtherCHEOF), CervoMed (CRVO) and Community Health (CYH)

TIPRANKS
·
Apr 24

CervoMed Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 23

Neflamapimod’s MRI and Connectivity Data Support Disease‑Modifying Potential in Dementia With Lewy Bodies and Underscore Buy Rating on CervoMed

TIPRANKS
·
Apr 23

CervoMed presents neflamapimod MRI data

TIPRANKS
·
Apr 22

CervoMed says neflamapimod boosts right basal forebrain volume in Lewy body dementia trial

Reuters
·
Apr 22

Roth MKM Remains a Buy on CervoMed (CRVO)

TIPRANKS
·
Apr 15

CervoMed Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Apr 08

CervoMed Highlights Neflamapimod Progress in Lewy Body Dementia

TIPRANKS
·
Apr 08

CervoMed says new Phase 2b MRI analysis supports neflamapimod slowing DLB progression

Reuters
·
Apr 07

CervoMed (CRVO) Gets a Buy from JonesTrading

TIPRANKS
·
Apr 07

CervoMed Posts Investor Presentation Under Regulation FD Disclosure

TIPRANKS
·
Mar 24

Cervomed Inc. Publishes Presentation Factsheet

Reuters
·
Mar 24

CervoMed Highlights RewinD-LB Phase 2b Biomarker-Driven Results

TIPRANKS
·
Mar 20

CervoMed Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE-Rivian,  Biohaven, CervoMed

Reuters
·
Mar 19